Neurokem NT 50 Tablet is a medicinal product formulated for managing neuropathic pain. This medication operates by hindering the transmission of pain signals to the brain, thereby alleviating discomfort associated with nerve-related pain. It can be ingested either with food or on an empty stomach, though it is generally recommended to take it at night. Consistency is key; taking it at the same time daily aids in maintaining stable levels of the medication in your bloodstream. It is essential to adhere to the dosage and duration prescribed by your healthcare provider. If a dose is forgotten, it should be taken promptly upon remembering, unless it is close to the time of the next scheduled dose. Completing the entire course of treatment is necessary, even if symptoms improve. Abruptly discontinuing the medication is not advised without consulting a healthcare professional first. Potential side effects may include constipation, nausea, disturbances in vision, and increased perspiration. Additional effects such as dizziness and drowsiness may also occur, necessitating caution when engaging in activities that require mental sharpness, such as driving. There is a possibility of weight gain with this medication, and it is advisable to incorporate regular physical activity and balanced nutritional choices into your routine. It is crucial to inform your physician of any unusual mood changes, worsening depression, or thoughts of self-harm during treatment. Prior to starting Neurokem NT 50 Tablet, disclose any history of kidney or liver issues to your doctor. Additionally, be sure to provide information about any other medications you are currently taking, as they may interfere with the effectiveness of this treatment. If you are pregnant, planning to become pregnant, or currently breastfeeding, you should discuss this with your healthcare provider.
-15%

NEUROKEM NT 50MG (Pregabalin (50mg) + Nortriptyline (10mg))
Original price was: ₹238.10.₹203.20Current price is: ₹203.20.
Add to cart
Buy Now
Reviews
There are no reviews yet.